Psychotropic medication prescribing for children and adolescents by general practitioners during the COVID-19 pandemic.
- Publisher:
- Wiley
- Publication Type:
- Journal Article
- Citation:
- Med J Aust, 2023, 219, (1), pp. 26-27
- Issue Date:
- 2023-07-03
Open Access
Copyright Clearance Process
- Recently Added
- In Progress
- Open Access
This item is open access.
Full metadata record
Field | Value | Language |
---|---|---|
dc.contributor.author | Hardie, R-A | |
dc.contributor.author | Sezgin, G | |
dc.contributor.author | Pont, LG | |
dc.contributor.author | Thomas, J | |
dc.contributor.author | Prgomet, M | |
dc.contributor.author | McGuire, P | |
dc.contributor.author | Pearce, C | |
dc.contributor.author | Georgiou, A | |
dc.date.accessioned | 2023-09-18T01:05:12Z | |
dc.date.available | 2023-04-05 | |
dc.date.available | 2023-09-18T01:05:12Z | |
dc.date.issued | 2023-07-03 | |
dc.identifier.citation | Med J Aust, 2023, 219, (1), pp. 26-27 | |
dc.identifier.issn | 0025-729X | |
dc.identifier.issn | 1326-5377 | |
dc.identifier.uri | http://hdl.handle.net/10453/172149 | |
dc.format | Print-Electronic | |
dc.language | eng | |
dc.publisher | Wiley | |
dc.relation.ispartof | Med J Aust | |
dc.relation.isbasedon | 10.5694/mja2.51942 | |
dc.rights | info:eu-repo/semantics/openAccess | |
dc.subject | 11 Medical and Health Sciences, 17 Psychology and Cognitive Sciences | |
dc.subject.classification | General & Internal Medicine | |
dc.subject.classification | 32 Biomedical and clinical sciences | |
dc.subject.classification | 42 Health sciences | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Child | |
dc.subject.mesh | Adolescent | |
dc.subject.mesh | General Practitioners | |
dc.subject.mesh | Pandemics | |
dc.subject.mesh | COVID-19 | |
dc.subject.mesh | Psychotropic Drugs | |
dc.subject.mesh | Mental Disorders | |
dc.subject.mesh | Practice Patterns, Physicians' | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Psychotropic Drugs | |
dc.subject.mesh | Mental Disorders | |
dc.subject.mesh | Adolescent | |
dc.subject.mesh | Child | |
dc.subject.mesh | General Practitioners | |
dc.subject.mesh | Pandemics | |
dc.subject.mesh | Practice Patterns, Physicians' | |
dc.subject.mesh | COVID-19 | |
dc.subject.mesh | Humans | |
dc.subject.mesh | Child | |
dc.subject.mesh | Adolescent | |
dc.subject.mesh | General Practitioners | |
dc.subject.mesh | Pandemics | |
dc.subject.mesh | COVID-19 | |
dc.subject.mesh | Psychotropic Drugs | |
dc.subject.mesh | Mental Disorders | |
dc.subject.mesh | Practice Patterns, Physicians' | |
dc.title | Psychotropic medication prescribing for children and adolescents by general practitioners during the COVID-19 pandemic. | |
dc.type | Journal Article | |
utslib.citation.volume | 219 | |
utslib.location.activity | Australia | |
utslib.for | 11 Medical and Health Sciences | |
utslib.for | 17 Psychology and Cognitive Sciences | |
pubs.organisational-group | /University of Technology Sydney | |
pubs.organisational-group | /University of Technology Sydney/Faculty of Health | |
utslib.copyright.status | open_access | * |
dc.date.updated | 2023-09-18T01:05:11Z | |
pubs.issue | 1 | |
pubs.publication-status | Published | |
pubs.volume | 219 | |
utslib.citation.issue | 1 |
Please use this identifier to cite or link to this item:
Download statistics for the last 12 months
Not enough data to produce graph